OBJECTIVE: Advanced paternal age is consistently associated with an increased risk for schizophrenia, accounting for up to a quarter of cases in some populations. If paternal age-related schizophrenia (PARS) involves a distinct etiopathology, then PARS cases may show specific characteristics, vis-à-vis other schizophrenia cases. This study examined if PARS exhibits the symptom profile and sex differences that are consistently observed for schizophrenia in general, wherein males have an earlier onset age and more severe negative symptoms than females. METHOD: Symptoms were assessed at baseline (admission) and during medication-free and treatment phases for 153 inpatients on a schizophrenia research unit, 38 of whom fulfilled operationally defined criteria for PARS (sporadic cases with paternal age > or = 35). RESULTS: Males and females with PARS had the same age at onset and a similar preponderance of negative symptoms, whereas the other (non-PARS) cases showed the typical earlier onset age and more severe negative symptoms in males. When medications were withdrawn, PARS cases showed significantly worse symptoms than non-PARS cases (higher total PANSS scores and positive, activation, and autistic preoccupation scores). However these symptoms globally improved with antipsychotic treatment, such that the differences between the PARS and other schizophrenia cases receded. CONCLUSION: The lack of sex differences in the age at onset and the greater severity of medication-free symptoms bolster the hypothesis that PARS has a distinct etiopathology. It also suggests that female sex does not exert a protective effect on the course of PARS, as it may in other forms of schizophrenia. 2009 Elsevier B.V. All rights reserved.
OBJECTIVE: Advanced paternal age is consistently associated with an increased risk for schizophrenia, accounting for up to a quarter of cases in some populations. If paternal age-related schizophrenia (PARS) involves a distinct etiopathology, then PARS cases may show specific characteristics, vis-à-vis other schizophrenia cases. This study examined if PARS exhibits the symptom profile and sex differences that are consistently observed for schizophrenia in general, wherein males have an earlier onset age and more severe negative symptoms than females. METHOD: Symptoms were assessed at baseline (admission) and during medication-free and treatment phases for 153 inpatients on a schizophrenia research unit, 38 of whom fulfilled operationally defined criteria for PARS (sporadic cases with paternal age > or = 35). RESULTS: Males and females with PARS had the same age at onset and a similar preponderance of negative symptoms, whereas the other (non-PARS) cases showed the typical earlier onset age and more severe negative symptoms in males. When medications were withdrawn, PARS cases showed significantly worse symptoms than non-PARS cases (higher total PANSS scores and positive, activation, and autistic preoccupation scores). However these symptoms globally improved with antipsychotic treatment, such that the differences between the PARS and other schizophrenia cases receded. CONCLUSION: The lack of sex differences in the age at onset and the greater severity of medication-free symptoms bolster the hypothesis that PARS has a distinct etiopathology. It also suggests that female sex does not exert a protective effect on the course of PARS, as it may in other forms of schizophrenia. 2009 Elsevier B.V. All rights reserved.
Authors: Stanley Zammit; Peter Allebeck; Christina Dalman; Ingvar Lundberg; Tomas Hemmingson; Michael J Owen; Glyn Lewis Journal: Br J Psychiatry Date: 2003-11 Impact factor: 9.319
Authors: Ossama El-Saadi; Carsten B Pedersen; Thomas F McNeil; Sukanta Saha; Joy Welham; Eadbhard O'Callaghan; Elizabeth Cantor-Graae; David Chant; Preben Bo Mortensen; John McGrath Journal: Schizophr Res Date: 2004-04-01 Impact factor: 4.939
Authors: Dolores Malaspina; Cheryl Corcoran; Cherine Fahim; Ariela Berman; Jill Harkavy-Friedman; Scott Yale; Deborah Goetz; Raymond Goetz; Susan Harlap; Jack Gorman Journal: Am J Med Genet Date: 2002-04-08
Authors: Alan S Brown; Catherine A Schaefer; Richard J Wyatt; Melissa D Begg; Raymond Goetz; Michaeline A Bresnahan; Jill Harkavy-Friedman; Jack M Gorman; Dolores Malaspina; Ezra S Susser Journal: Am J Psychiatry Date: 2002-09 Impact factor: 18.112
Authors: Emma M Frans; John J McGrath; Sven Sandin; Paul Lichtenstein; Abraham Reichenberg; Niklas Långström; Christina M Hultman Journal: Schizophr Res Date: 2011-10-14 Impact factor: 4.939
Authors: Daniel Antonius; David Kimhy; Jill Harkavy-Friedman; Sarah Crystal; Ray Goetz; Dolores Malaspina Journal: Schizophr Res Date: 2010-10-30 Impact factor: 4.939
Authors: Hyejoo Lee; Dolores Malaspina; Hongshik Ahn; Mary Perrin; Mark G Opler; Karine Kleinhaus; Susan Harlap; Raymond Goetz; Daniel Antonius Journal: Schizophr Res Date: 2011-02-26 Impact factor: 4.939
Authors: Brandon Abbs; Rashmin M Achalia; Adegoke O Adelufosi; Ahmet Yiğit Aktener; Natalie J Beveridge; Savita G Bhakta; Rachael K Blackman; Emre Bora; M S Byun; Maurice Cabanis; Ricardo Carrion; Christina A Castellani; Tze Jen Chow; M Dmitrzak-Weglarz; Charlotte Gayer-Anderson; Felipe V Gomes; Kristen Haut; Hiroaki Hori; Joshua T Kantrowitz; Taishiro Kishimoto; Frankie H F Lee; Ashleigh Lin; Lena Palaniyappan; Meina Quan; Maria D Rubio; Sonia Ruiz de Azúa; Saddichha Sahoo; Gregory P Strauss; Aleksandra Szczepankiewicz; Andrew D Thompson; Antonella Trotta; Laura M Tully; Hiroyuki Uchida; Eva Velthorst; Jared W Young; Anne O'Shea; Lynn E Delisi Journal: Schizophr Res Date: 2012-08-19 Impact factor: 4.939
Authors: Ali B Rodgers; Christopher P Morgan; Stefanie L Bronson; Sonia Revello; Tracy L Bale Journal: J Neurosci Date: 2013-05-22 Impact factor: 6.167
Authors: Mark Opler; Dolores Malaspina; Srihari Gopal; Isaac Nuamah; Adam J Savitz; Jaskaran Singh; David Hough Journal: Schizophr Res Date: 2013-10-18 Impact factor: 4.939
Authors: Christy L M Hui; Cindy P Y Chiu; Yuet-Keung Li; Chi-Wing Law; Wing-Chung Chang; Sherry K W Chan; Edwin H M Lee; Pak Sham; Eric Y H Chen Journal: Can J Psychiatry Date: 2015-08 Impact factor: 4.356